A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Clinical trial NCT00314145 · COMPLETED

Trial details

NCT number: NCT00314145
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2005-11-01
Primary completion: 2006-06-01
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.